Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Hormones and the Endocrine System > Liraglutide for Sale > Liraglutide | GLP-1 Peptides | 99% Purity | CAS 204656-20-2 | White Powder | Diabetes & Weight Loss
Liraglutide | GLP-1 Peptides | 99% Purity | CAS 204656-20-2 | White Powder | Diabetes & Weight Loss buy - large image1
Liraglutide | GLP-1 Peptides | 99% Purity | CAS 204656-20-2 | White Powder | Diabetes & Weight Loss buy - image1

Liraglutide | GLP-1 Peptides | 99% Purity | CAS 204656-20-2 | White Powder | Diabetes & Weight Loss

GMP FDA COA 29 Inquiries

Unit Price: Get Latest Price
CAS No.:

204656-20-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Beijing

Packaging:

5g/10g/20g/50g/100g/500g/1000g

Price valid (until):

2026-05-10

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Tirzepatide,Semaglutide,Retatrutide,Liraglutide,Semax,Acetate

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Liraglutide 
    GLP-1 Receptor Agonist Peptide | High Purity 99%

    CAS No.: 204656-20-2

    Appearance: White Powder

    Molecular Formula: C172H265N43O51

    Liraglutide is a long-acting GLP-1 receptor agonist peptide widely used in metabolic regulation-related applications. It is known for its strong performance in glucose balance support, appetite regulation, and energy metabolism control, making it a key compound in modern metabolic health solutions.

    With its well-characterized activity profile and stable molecular structure, Liraglutide is widely recognized for supporting weight management systems and metabolic optimization pathways.

    🔥 Product Advantages

    ✔ High Purity ≥99%
    ✔ Excellent Chemical Stability
    ✔ Long-Acting Activity Profile
    ✔ High Batch-to-Batch Consistency
    ✔ Strong Biological Activity Performance
    ✔ Scalable Production Capacity (100–200 kg)

    💡 Key Functional Focus

    • Glucose regulation support
    • Appetite and satiety balance
    • Energy metabolism optimization
    • Weight management applications
    • Metabolic pathway modulation

    Liraglutide is a well-established GLP-1 compound with strong market demand, widely used in metabolic health and weight management-related applications, offering fully documentation and consistent quality for commercial use.

    Contact Us

    Ms. Iris

    Tel/Whatsapp:+86 13002751028

    Email: Irisbian@transcoasvia.com

    Orforglipron – High-Purity GLP-1 Receptor Agonist (RUO)

    CAS: 2212020-52-3 | ≥99% Purity | White Powder

    Orforglipron is a next-generation oral GLP-1 receptor agonist designed for advanced metabolic research. It plays a key role in studies of glucose regulation, appetite control, and energy balance pathways, making it a highly valuable compound in diabetes and obesity-related research. 

    Compared with traditional peptide GLP-1 analogs, Orforglipron offers improved oral activity and strong receptor selectivity, supporting more flexible experimental design in metabolic studies.

    Widely used in research focusing on:
    • GLP-1 receptor signaling mechanisms
    • Blood glucose regulation pathways
    • Obesity and weight management models
    • Appetite and energy metabolism studies
    • Incretin-based drug discovery research

    Product Highlights:
    ✔ High Purity ≥99%
    ✔ Excellent Stability
    ✔ Consistent Batch Quality
    ✔ Scalable Production (100–200 kg)
    ✔ Suitable for R&D and laboratory use

    Orforglipron is a key reference compound in modern incretin research and is often studied alongside advanced metabolic agents to better understand multi-pathway glucose and weight regulation systems.

    ⚠ Research Use Only (RUO) 

    Specifications
    White powder
    Purity ≥ 99%
    Bacterial endotoxins: <10EU/mg


      Company IntroductionShop Liraglutide | GLP-1 Peptides | 99% Purity | CAS 204656-20-2 | White Powder | Diabetes & Weight Loss-Detailed Image 1 Shop Liraglutide | GLP-1 Peptides | 99% Purity | CAS 204656-20-2 | White Powder | Diabetes & Weight Loss-Detailed Image 2  


    Certificates

    Basic Info
    Product Name:

    Liraglutide

    CAS No.:

    204656-20-2

    Hazard Identification

    Classification of the substance or mixture

    Carcinogenicity, Category 2

    Reproductive toxicity, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H351 Suspected of causing cancer

    H361 Suspected of damaging fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Tirzepatide,Semaglutide,Retatrutide,Liraglutide,Semax,Acetate

    Location:

    Qingtie Plaza, No. 118 Changjiang West Road, Huangdao District

    Payment Terms:

    O/A,100% TT in advance

    Average lead Time:

    5

    Total Annual Revenue:

    $10 million-$25 million

    Total Employees:

    11-50

    Year of Establishment:

    2019

  • Inquiry History
    29 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    China factory wholesale price supply high purity 99% cas 204656-20-2 Liraglutide injection

    50 KG Sep 30, 2023
    India

    Liraglutide

    1.00 KG Oct 8, 2024
    India

    Liraglutide-USP

    150.00 G Oct 10, 2023
    United Kingdom

    Liraglutide

    20 MG Jul 8, 2026
    United States

    MIC

    2 MT May 20, 2026
    United States

    Mic (Lipo C with B12), VIP, Ss31, glutathione and, Reta

    50 MG Mar 4, 2026
    Canada

    Liraglutide

    1 KG Dec 8, 2025
    United States

    liraglutide

    1 MT Nov 22, 2025
    Brazil

    Liraglutida

    1 G Sep 29, 2025
    United States

    Liraglutide

    1 KG Aug 13, 2025
    Sweden

    liraglutide

    1 KG Aug 4, 2025
    Pakistan

    liraglutide injection

    50 KG Jan 21, 2025
    India

    Liraglutide

    10 MG Jul 17, 2024
    United States

    Peptide Liraglutide/Victoza/Liraglutida 98% Powder 67-51-6 Weight Loss Senwayer

    1 KG Sep 30, 2023
    Jordan

    Liraglutide

    1.00 MT Sep 19, 2023
    United States

    liraglutide

    Jan 21, 2026
    Turkey

    Liraglutide

    5 MG Jul 4, 2025
    Reunion Island

    Liraglutide

    1 G Apr 14, 2025
    Pakistan

    liraglutide

    500 MG Feb 19, 2025
    India

    Liraglutide

    100.00 KG Nov 7, 2023
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.